ASA & OCE – “Statistics in Oncology Clinical Trials”, 8 October 2020

The Methods in Oncology scientific working group of the American Statistical Association (ASA)  in collaboration with the  FDA Oncology Center of Excellence (OCE) will hold a forum on “Type I error Considerations in Master Protocols with Common Control in Oncology Clinical Trials” next October, 8th.

Martin Posch, professor of Medical Statistics at the Medical University of Vienna, head of the Center for Medical Statistics, Informatics and Intelligent Systems, and member of EU-PEARL will present the project and its scientific and methodological approach to a new paradigm of platform trials. Posch will share the floor with speakers from the European Medicines Agency (EMA), the Food and Drug Administration (FDA) and industry representatives.

The event is addressed to members of ASA working groups and regulatory agencies and intends to foster collaboration among professional organizations, regulators, industry, academicians, and patients to advance drug development with improved design of cancer clinical trials.